is dedicated to World Cancer Research Day and is our contribution within the framework of the international ECHoS project to raising awareness about cancer and the need for broad stakeholder engagement. As a foundation that emphasizes the importance of research – because Where Science Becomes Art, Treatment Emerges as Its Masterpiece – we want to present a “taste of its fruits” to all five ABCGM sectors of the pentahelix ecosystem platform (Academia, Business, Community, Government, and Media), which co-create and implement precision medicine solutions for cancer.
The conference is divided into three thematic areas.
The first assesses the significance of CCC in the European context. It emphasizes the organizational framework needed to align stakeholder positions with preparation of the Slovak Comprehensive Cancer Centre accreditation and the creation of the National Cancer Mission hub in Slovakia. Also offers a perspective on multidisciplinary collaboration between institutions of the Slovak Academy of Sciences and Medical Faculties and their clinics. (block 1 presentations)
The second addresses prehabilitation and rehabilitation as essential components of comprehensive cancer care. It will showcase examples of good clinical practice from abroad, including domestic initiatives such as obesity management, and the role of research in applying these practices. (block 2 presentations)
The third offers a broad spectrum of scientific presentations, covering basic, translational, and clinical research. Topics include tumor microenvironment heterogeneity, nerve–tumor interactions, the influence of circadian rhythm on molecular processes, the collection and evaluation of international study data, and the use of artificial intelligence to guide cancer treatment. (block 3 and block 4 presentations)
| 9:00 |
Conference opening – R. Crevenna‘ recorded greeting |
| Block I. – – 9:05 – 10:25 | |
| Eva Jolly, Karolinska Comprehensive Cancer Center, Stockholm, Sweden Strengthening Cancer Policy through Comprehensive Cancer Centers and Mission Hubs |
|
| Silvia Pastoreková, Biomedical Research Center SAS, Bratislava, Slovakia; Scientific Council of the Slovak Academy of Sciences From Models to Medicine: Experimental Oncology as the Foundation of Clinical Care. The role of the Slovak Academy of Sciences. |
|
|
Peter Valkovič, Scientific Board of the Ministry of Health, Slovak Republic; Medical Faculty, Comenius University Bratislava, Slovakia |
|
| Soňa Čierniková, National Cancer Institute; coordinator of ECHoS, CCI4EU, EUnetCCC-JA activities in Slovakia, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava, Slovakia Towards a Patient-Centered and Mission-driven Cancer Ecosystem: Slovakia’s Path to Comprehensive Cancer Care and National Cancer Mission Hub |
|
| Daniela Světlovská, Department of Clinical Trials, National Cancer Institute, Bratislava, Slovakia 30 years of Clinical Trials Department in National Cancer Institute, Slovakia |
|
| 10:25 | Coffee break – Networking |
| Block II. – – 10:50 – 12:30 | |
|
Jennifer A. Ligibel, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA |
|
| Petra Sládková, Rehabilitation Clinics of the Bulovka University Hospital and the Faculty of Biomedical Engineering of the Czech Technical University, Prague, Czech Republic Multimodal Prehabilitation in Oncology: Current Options and Perspectives |
|
| Barbara Ukropcová, Institute of Experimental Endocrinology, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava, Slovakia Health benefits of aerobic-strength training in TGCT cancer survivors |
|
| Richard Crevenna, Department of Physical Medicine, Rehabilitation and Occupational Medicine, Medical University of Vienna, Austria Cancer Prehabilitation and Rehabilitation – The Austrian Approach |
|
| 12:30 | LUNCH |
| Block III. – – 13:15 – 14:55 | |
| Shiv K. Singh, Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center Göttingen, Germany Emerging Mechanisms of Spatial Heterogeneity Driving Therapy Resistance in Pancreatic Cancer |
|
| Bruno Sainz, Cancer Stem Cells and Fibroinflammatory Microenvironment Group Instituto de Investigaciones Biomédicas Sols-Morreale (IIBM) – CSIC-UAM, Madrid, Spain Turning Foes into Allies: Nanoparticle Re-education of Macrophages Against Pancreatic Cancer Metastasis |
|
| Michal Kováč, brAInworks Laboratories, Faculty of Informatics and Information Technologies, Slovak University of Technology in Bratislava, Slovakia How Far Can AI Go in Guiding Cancer Treatment |
|
| Eva Steliarova-Foucher, International Agency for Research on Cancer, World Health Organization, Lyon, France Use of surveillance data in international studies of childhood cancer |
|
| 14:55 | Coffee break – Networking |
| Block IV. – – 15:15 – 16:55 | |
| Iveta Herichová, Department of Animal Physiology and Ethology, Faculty of Natural Sciences, Comenius University, Bratislava, Slovakia Interferences in miRNA and the circadian system in colorectal cancer progression |
|
| Ingrid Garajová, Medical Oncology Unit, University Hospital of Parma, Italy Tumor Microenvironment and Tumor-Neural Cell Interaction in Pancreatic Cancer |
|
| Jana Jakubíková, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava, Slovakia Myeloma Uncovered: From Cells to Clinic via Mass Cytometry |
|
| Lucia Kučerová, Translational Research Unit, 2nd Oncology Clinic of the Medical Faculty, Comenius University, and the National Cancer Institute, Bratislava, Slovakia Recent Advances in Translational Cancer Research in Germ Cell Tumors in Slovakia |
|
| 16:55 | Closing of the Conference |
